Antonina Rait
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- RNA Interference and Gene Delivery 17
- Advanced biosensing and bioanalysis techniques 10
- DNA and Nucleic Acid Chemistry 5
- Oncology 12
- Cancer-related Molecular Pathways 6
- Co-authors
- Esther H. Chang (39 shared papers)Kathleen F. Pirollo (34 shared papers)Sang Soo Kim (12 shared papers)Liang Xu (4 shared papers)Wenhua Tang (4 shared papers)Laiman Xiang (5 shared papers)Eric H. Kim (3 shared papers)Qi Zhou (4 shared papers)
- Journals
- Human Gene Therapy (4 papers)Molecular Therapy (3 papers)Cancer Gene Therapy (3 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesNetherlandsJapan
In The Last Decade
Antonina Rait
40 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 93
- Biomaterials 748
- Cancer Research 375
- Biotechnology 220
- Molecular Biology 1.6k
- Oncology 527
Countries citing papers authored by Antonina Rait
This map shows the geographic impact of Antonina Rait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonina Rait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonina Rait more than expected).
Fields of papers citing papers by Antonina Rait
This network shows the impact of papers produced by Antonina Rait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonina Rait. The network helps show where Antonina Rait may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonina Rait, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 206 | |
| 2 | Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. | 2002 | 206 |
| 3 | 1999 | 190 | |
| 4 | 2007 | 163 | |
| 5 | 2014 | 137 | |
| 6 | 2006 | 124 | |
| 7 | 2001 | 122 | |
| 8 | 2017 | 111 | |
| 9 | 1997 | 105 | |
| 10 | 2015 | 101 | |
| 11 | 2013 | 95 | |
| 12 | 2014 | 93 | |
| 13 | 2002 | 93 | |
| 14 | 2003 | 90 | |
| 15 | Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment. | 2004 | 82 |
| 16 | 2004 | 76 | |
| 17 | 2004 | 69 | |
| 18 | 1997 | 64 | |
| 19 | 2002 | 52 | |
| 20 | 2008 | 52 |
About Antonina Rait
Antonina Rait is a scholar working on Molecular Biology, Oncology, Biotechnology, Cancer Research and Biomaterials, having authored 41 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (17 papers), Advanced biosensing and bioanalysis techniques (10 papers), Cancer-related Molecular Pathways (6 papers), Cancer Research and Treatments (6 papers), Nanoparticle-Based Drug Delivery (5 papers), DNA and Nucleic Acid Chemistry (5 papers), MicroRNA in disease regulation (5 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Biomaterials (748 citations), Cancer Research (375 citations), Biotechnology (220 citations), Molecular Biology (1.6k citations) and Oncology (527 citations). Antonina Rait has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include Esther H. Chang, Kathleen F. Pirollo, Sang Soo Kim, Liang Xu, Wenhua Tang, Laiman Xiang, Eric H. Kim, Qi Zhou, John A. Dagata and Richard I. Hogrefe. Their work appears in journals such as Human Gene Therapy, Molecular Therapy, Cancer Gene Therapy, Nanomedicine Nanotechnology Biology and Medicine and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.